Key Points - 2021 Q3 Filed November 15, 2021
Total
Key Points - 2021 Q3 Filed November 15, 2021
Total Sales: $2,623,735
Total Cost of Goods Sold: $2,133,915
Gross Profit: $489,820
Total Operating Costs: $434,653
Net Profit: $55,167 - so flipped positive for the first time as expected
Total Assets: $1,398,486
Cash at Beginning of Period: $3,392
Net Cash Increase During Period: $45,847
Cash at End of Period: $49,239
SFLMaven, Inc. (SFLM) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Gathering for a New Kind of Celebration With a buzz louder than a crowded trading floor on a bull day, folks are flocking to catch the ripple effect of "Dedicate." Over 2 million views already, and it hasn't even hit the major radar yet—that's some serious fire in the storytelling world. The premiere in Manila, held at the Missionary Training Center (MTC), was no small...
Continue Reading
Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...
Continue Reading
Rethinking AI with Sovereignty in Mind A bouquet of tech buzzwords lands on every investor's doorstep with the unveiling of Context Labs' latest contraption. We’re talking about the AI Distillery™, which promises enterprises a way to run sovereign AI systems by keeping data in-house. Now, if you’re nodding along to the buzz, let's cut through the clutter....
Continue Reading
Investors Eye Deadline Amidst Legal Storm Holy moly, Tenax Therapeutics is caught with their pants down—and we're not talking loose change. Any sorry soul who bought into Tenax's promises about their TNX-103 drug is now staring down a high-stakes class action lawsuit. If you were holding on to those dreams turned nightmares between November 13, 2023, and August 7, 2026,...
Continue Reading
Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...
Continue Reading
Small Component, Big Impact: The Anode Rod Picture this: You’ve got a trusty water heater keeping your showers steamy, but lurking inside is a villain called rust. Enter the unsung hero—the anode rod. It might not be glamorous, but this little piece of metal works overtime to save your tank from a watery grave. Tim Fessler and Dave Super, seasoned plumbing hotshots...
Continue Reading
Unlocking the Mysteries of Knob-and-Tube Wiring Ever wondered if the wiring in your charming hundred-year-old home might be a ticking time bomb? Welcome to the world of knob-and-tube wiring. This blast from the past might just be hiding in those walls and could spell trouble. The History and Hazards of Knob-and-Tube This wiring system dates back to the 1880s, sticking...
Continue Reading
Understanding Pain: Two Paths, One Problem Buttock and leg pain is a real drag, isn't it? We often brush it off as sciatica, but here's a twist: it might not be the usual corporate villain—a herniated disc. Instead, we could be dealing with an underdog called piriformis syndrome. According to Dr. Mitch Quill, D.C., of HelloNation fame, understanding these nuances isn't...
Continue Reading
Gildan's Legal Storm: Fraud Allegations When news hits about a big player like Gildan Activewear (NYSE: GIL) facing a class-action lawsuit, it's like a thunderstorm for investors who traded their stocks between February 19, 2025, and June 15, 2026. This lawsuit alleges what we some might call classic financial engineering—channel stuffing to be precise—that’s got...
Continue Reading
A New Era of Touring Japan: Meet Naviu Alright, travelers, strap in—Naviu is about to flip your trip to Japan upside down. Launching November 1st, 2026, this AI-powered augmented reality travel companion is trying to make exploring Japan easier than ever. Behind this innovative gem is TANGLE Inc., working with technology so cutting-edge, it's practically slicing through...
Continue Reading
Top 5 Most Recently Viewed Articles
Corporate Reorganization Announcement by GoldHaven Resources VANCOUVER, British Columbia — GoldHaven Resources Corp. ('GoldHaven' or the 'Company') (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) has completed a significant reorganization of its corporate structure. Details of the Reorganization This restructuring, which took place recently, includes a vertical short form...
Continue Reading
Understanding Restorative Dentistry Restorative dentistry plays a vital role in the field of oral health, focusing on not just repairing damage but enhancing the functionality of the teeth. Dr. John W. Barone, a family dentistry expert, explains how these procedures extend beyond cosmetic improvements and address critical aspects of oral health. What is Restorative...
Continue Reading
Exploring the Future of Global Custom Software Development The Custom Software Development Market is on an impressive growth trajectory, with its current valuation at USD 34.84 billion and an anticipated climb to USD 206.61 billion by the end of the forecast period. This remarkable expansion, projected to grow at a compound annual growth rate (CAGR) of 21.9%, highlights...
Continue Reading
Richardson Electronics Reports Mixed First Quarter Results Richardson Electronics, Ltd. (RELL) has published its mixed results for the first quarter of fiscal year 2025. While net sales increased by 2.2%, reaching $53.7 million compared to the previous year, the company has exhibited substantial growth in its green energy and healthcare sectors. Despite challenges faced...
Continue Reading
Photocure ASA Sees Growth in Q4 2024 Results Photocure ASA (OSE:PHO) has shared some remarkable results for the fourth quarter of 2024. Their revenues from Hexvix and Cysview have reached NOK 128.6 million, reflecting an impressive 13% growth compared to the prior year's quarter. Alongside this, the company achieved an EBITDA of NOK 8.5 million, maintaining strong...
Continue Reading